Skip to main content

Lee Zou

George Barth Geller Distinguished Professor
Pharmacology & Cancer Biology

Current Duke Appointments & Affiliations


George Barth Geller Distinguished Professor · 2024 - Present Pharmacology & Cancer Biology, Basic Science Departments
Professor of Pharmacology and Cancer Biology · 2023 - Present Pharmacology & Cancer Biology, Basic Science Departments
Chair, Department of Pharmacology and Cancer Biology · 2023 - Present Pharmacology & Cancer Biology, Basic Science Departments
Member of the Duke Cancer Institute · 2023 - Present Duke Cancer Institute, Institutes and Centers

Recent News Items


Published March 19, 2024
Duke Awards 32 New Distinguished Professorships for 2024
Published November 9, 2023
Immunotherapy Plus an Investigational Cancer Drug Improves Anti-Tumor Effects

View All News Items

Recent Scholarly Works


CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Journal article Cancer Res · October 2, 2026 UNLABELLED: Intrinsic and acquired resistance to CDK4/6 inhibitors (CDK4/6i) is a critical challenge in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC). CDK2 inhibitors (CDK2i) show ... Full text Link to item Cite

Replication stress in cancer: origins, consequences and therapeutic opportunities.

Journal article Nat Rev Cancer · September 22, 2026 Replication stress, defined as impaired DNA replication leading to genomic instability, is a central feature of tumour development and progression. In cancer cells, it arises from oncogene activation, transcription-replication conflicts, altered nucleotide ... Full text Link to item Cite

Capturing ATR-ATRIP in the act of activation.

Journal article Nat Struct Mol Biol · September 17, 2026 Full text Link to item Cite
View All Scholarly Works

Recent Grants


Genetics and Genomics Training Grant

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2026 - 2031

ABL kinase signaling networks regulate Transcription-Replication Collisions in Small Cell Lung Cancer

ResearchCollaborating Investigator · Awarded by National Institutes of Health · 2026 - 2031

Therapeutic targeting of SMARCAL1 in therapy-resistant gliomas

ResearchCo Investigator · Awarded by National Institutes of Health · 2026 - 2031

View All Grants

Education


Stony Brook University · 1999 Ph.D.